Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition
dc.contributor.author | Goyard, David | |
dc.contributor.author | Kónya, Bálint | |
dc.contributor.author | Chajistamatiou, Aikaterini S. | |
dc.contributor.author | Chrysina, Evangelia D. | |
dc.contributor.author | Leroy, Jérémy | |
dc.contributor.author | Balzarin, Sophie | |
dc.contributor.author | Tournier, Michel | |
dc.contributor.author | Tousch, Didier | |
dc.contributor.author | Petit, Pierre | |
dc.contributor.author | Duret, Cédric | |
dc.contributor.author | Maurel, Patrick | |
dc.contributor.author | Somsák, László | |
dc.contributor.author | Docsa, Tibor | |
dc.contributor.author | Gergely, Pál | |
dc.contributor.author | Praly, Jean-Pierre | |
dc.contributor.author | Azay-Milhau, Jacqueline | |
dc.contributor.author | Vidal, Sébastien | |
dc.date.accessioned | 2016-01-21T09:40:43Z | |
dc.date.available | 2016-01-21T09:40:43Z | |
dc.date.issued | 2016 | |
dc.date.pasync | 2024-09-27T23:08:15Z | |
dc.date.updated | 2017-12-01T09:37:46Z | |
dc.identifier.citation | European Journal of Medicinal Chemistry. -108 (2016), p. 444-454. -Eur. J. Med. Chem. - 0223-5234 1768-3254 | |
dc.identifier.doi | http://dx.doi.org/10.1016/j.ejmech.2015.12.004 | |
dc.identifier.issn | 1768-3254 | |
dc.identifier.issn | 0223-5234 | |
dc.identifier.opac | http://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM062009 | |
dc.identifier.scopus | 84950153946 | |
dc.identifier.uri | http://hdl.handle.net/2437/221468 | |
dc.identifier.url | http://linkinghub.elsevier.com/retrieve/pii/S0223523415303901 | |
dc.identifier.wos | 000369191800039 | |
dc.language | eng | |
dc.rights.access | open access pre-print és post-print (24h embargó) | |
dc.rights.owner | Elsevier | |
dc.subject.mab | Természettudományok | |
dc.subject.mab | Kémiai tudományok | |
dc.subject.mab | Orvostudományok | |
dc.subject.mab | Elméleti orvostudományok | |
dc.title | Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition | |
dc.type | folyóiratcikk | |
dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |